MORGAN STANLEY PLC/CALL/CENTENE/80/0.1/20.06.25 Share Price

Warrant

DE000ME30T29

Market Closed - Börse Stuttgart 12:28:03 04/07/2024 am IST
0.4 EUR +5.26% Intraday chart for MORGAN STANLEY PLC/CALL/CENTENE/80/0.1/20.06.25
Current month+5.26%
1 month-32.20%
Date Price Change
03/24/03 0.4 +5.26%
02/24/02 0.38 +11.76%
01/24/01 0.34 -10.53%
28/24/28 0.38 -7.32%
27/24/27 0.41 -2.38%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 12:28 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CENTENE CORPORATION
Issuer Morgan Stanley
WKN ME30T2
ISINDE000ME30T29
Date issued 02/11/2023
Strike 80 $
Maturity 20/06/2025 (352 Days)
Parity 10 : 1
Emission price 0.99
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.34
Lowest since issue 0.34
Delta0.38x
Omega 5.736
Premium26.54x
Gearing14.92x
Moneyness 0.8345
Difference Strike 13.24 $
Difference Strike %+16.55%
Spread 0.03
Spread %6.98%
Theoretical value 0.4150
Implied Volatility 29.63 %
Total Loss Probability 72.06 %
Intrinsic value 0.000000
Present value 0.4150
Break even 84.48 €
Theta-0.01x
Vega0.02x
Rho0.02x

Company Profile

Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
-
More about the company

Ratings for Centene Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Centene Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
66.76 USD
Average target price
87.52 USD
Spread / Average Target
+31.09%
Consensus